MedTrace Logo

Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus

NCT03988699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2026-02-27

No results posted yet for this study

Summary

Researchers are gathering information on the safety and effectiveness of a novel device called the Tinnitus Implant System for the treatment of tinnitus.

Conditions

  • Tinnitus

Interventions

DEVICE

Tinnitus Implant System

Device will deliver stimulation below hearing thresholds continuously or intermittently.

Sponsors & Collaborators

  • Matthew L. Carlson, M.D.

    lead OTHER

Principal Investigators

  • Matthew L Carlson, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2024-09-10
Completion
2024-09-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03988699 on ClinicalTrials.gov